National Health Act 1953 Amendment determination under paragraph 98C(1)(b) conditions (No. PB 45 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 45 of 2008

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated    Second of April     2008

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — conditions

1              Commencement  

This instrument commences on 1 May 2008.

2              Amendment of PB 52 of 2007

Schedule 1 amends PB 52 of 2007.

Schedule 1        Amendments

[1]     Schedule 1, after item dealing with Flucloxacillin with Water – Purified BP in the form Powder for oral suspension 125 mg (as magnesium) per 5 mL, 100 mL

insert in the column headed “Form (strength, type, size, etc.)”:

Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mL

[2]     Schedule 1, after item dealing with Flucloxacillin with Water – Purified BP in the form Powder for oral suspension 250 mg (as magnesium) per 5 mL, 100 mL

insert in the column headed “Form (strength, type, size, etc.)”:

Powder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL

[3]     Schedule 4, after item dealing with Flucloxacillin in the form Powder for oral suspension 125 mg (as magnesium) per 5 mL, 100 mL

insert in the column headed “Form (strength, type, size, etc.)”:

Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mL

[4]     Schedule 4, after item dealing with Flucloxacillin in the form Powder for oral suspension 250 mg (as magnesium) per 5 mL, 100 mL

insert in the column headed “Form (strength, type, size, etc.)”:

Powder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL

[5]     Schedule 4, item dealing with Macrogol 3350

insert as first entry in the column headed “Form (strength, type, size, etc.)”:

Sachets containing powder for oral solution 6.563 g with electrolytes, 30

[6]     Schedule 4, after item dealing with Risedronic Acid and Calcium

insert in the columns in the order indicated:

Risedronic acid and calcium with colecalciferol Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms

[7]     Schedule 4, item dealing with Salmeterol

omit from the column headed “Form (strength, type, size, etc.)”:

Pressurised inhalation 25 micrograms (as xinafoate) per dose, 120 doses